UHealth - University of Miami Health System

Ali Ghodsizad, M.D., Ph.D.

Información general

Ali  Ghodsizad, M.D., Ph.D.

Contacto

Idiomas

  • English
  • Persian
  • German

Especialidades

  • Thoracic Surgery (Cardiothoracic Vascular Surgery)

Puestos

  • Assistant Professor of Surgery

Biografía

Ali Ghodsizad, M.D., PhD., FACC, FETCS 

Dr. Ali Ghodsizad is a cardiovascular and thoracic surgeon specializing in the therapy of advanced heart and lung disease. He is an active clinician performing the whole spectrum of cardiovascular and lung surgery.

He grew up in Dusseldorf, Germany and received his medical degree from the Medical School of Hanover in Germany in 2001. He received his post-graduate training in leading centers in Europe and the USA, including the University of Heidelberg, Texas Heart Institute and Temple University Hospital. He is Board Certified in Cardiovascular and Thoracic Surgery.

In the last 3 years he was working as an attending and Assistant Professor of Surgery at the Penn State Milton S. Hershey Medical Center and Temple University Hospital, focusing on treatment of end stage heart and respiratory failure, transplantation and as the Director of the Mechanical Circulatory Support Research.

He has been an Associate Professor of Cardiac Surgery at the University of Heidelberg since 2013. He recently joined the Division of Heart and Lung Transplantation and Assist Support Device Therapy at the Miami Transplant Institute, a unique affiliation between Jackson Health System at the University of Miami Health System, as a full time Cardiothoracic Surgery faculty member and Director of the ECMO program. His area of expertise involves adult thoracic and cardiac surgery with focus on thoracic transplantation and mechanical circulatory support, ECMO, Ex-Vivo organ perfusion, TAVR and total artificial heart.

He currently leads the Thoracic Transplantation Ex-Vivo program at the Miami Transplant Institute and Jackson Health System.

His pioneering work in application of coronary angiography using the Organ Care System ex-vivo device was worldwide the first available publication describing expedited allograft evaluation using the ex-vivo technology.

He has been working on optimized techniques to perform allograft preconditioning during ex-vivo organ treatment, including stem cell and gene therapy.

He is a Fellow of the ACC and the European Board of Thoracic and Cardiac Surgery.

Dr. Ali Ghodsizad’s research has focused on clinical stem cell application for cardiac and lung disease, tissue engineering, gene therapy, recellularization of organ specific matrixes and TAVR for the last 20 years. In addition, a wide spectrum of scientific issues relating to Thoracic and cardiovascular surgery have been covered by over 80 publications.

E-mail a Friend